HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G J Tsioulias Selected Research

polyvalent melanoma cell vaccine

4/2001Serum TA90 antigen-antibody complex as a surrogate marker for the efficacy of a polyvalent allogeneic whole-cell vaccine (CancerVax) in melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G J Tsioulias Research Topics

Disease

6Neoplasms (Cancer)
10/2001 - 06/2000
2Neoplasm Micrometastasis
07/2001 - 11/2000
2Melanoma (Melanoma, Malignant)
04/2001 - 08/2000
1Hemorrhage
09/2001
1Polyps
07/2001
1Colorectal Neoplasms (Colorectal Cancer)
03/2001
1Liver Neoplasms (Liver Cancer)
06/2000
1Thrombocytopenia (Thrombopenia)
06/2000

Drug/Important Bio-Agent (IBA)

2iso-sulfan blue (Lymphazurin)FDA LinkGeneric
07/2001 - 08/2000
2Coloring Agents (Dyes)IBA
07/2001 - 08/2000
2Keratins (Keratin)IBA
07/2001 - 11/2000
1CarbonIBA
07/2001
1chinese inkIBA
07/2001
1polyvalent melanoma cell vaccineIBA
04/2001
1Antigen-Antibody Complex (Immune Complex)IBA
04/2001
1AntigensIBA
04/2001
1VaccinesIBA
04/2001
1Biomarkers (Surrogate Marker)IBA
04/2001
1Glycoproteins (Glycoprotein)IBA
04/2001

Therapy/Procedure

2Lymph Node Excision (Lymph Node Dissection)
10/2001 - 08/2000
2Radiofrequency Ablation
09/2001 - 06/2000
2Therapeutics
04/2001 - 11/2000
1Laparotomy
09/2001
1Colonoscopes
07/2001
1Colectomy
07/2001
1Adjuvant Chemotherapy
03/2001
1Length of Stay
06/2000